search
Back to results

Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery

Primary Purpose

Scoliosis; Adolescence

Status
Completed
Phase
Phase 3
Locations
Korea, Republic of
Study Type
Interventional
Intervention
intravenous acetaminophen
intravenous acetaminophen
Placebo
Sponsored by
Asan Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Scoliosis; Adolescence focused on measuring scoliosis, acetaminophen

Eligibility Criteria

11 Years - 20 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) physical status 1-3
  • patients undergoing spinal fusion surgery

Exclusion Criteria:

  • patients who refuse to participate in this study
  • patients unable to communicate due to mental impairment or developmental delay
  • patients allergic to acetaminophen or its additives or who are contraindicated in acetaminophen administration for other reasons
  • patients with existing liver diseases or dysfunction (i.e. active hepatitis, clinically relevant chronic liver conditions, elevated liver enzymes)
  • patients who are judged ineligible by the medical staff to participate in the study for other reasons

Sites / Locations

  • Asan Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

Experimental (Pre): Acetaminophen

Experimental(post): Acetaminophen

Placebo comparator : placebo

Arm Description

Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg after anesthetic induction/before surgical incision and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given at the end of surgery before skin closure.

Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg at the end of surgery before skin closure and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given after anesthetic induction/before surgical incision.

Participants will receive 1.5ml/kg placebo (0.9% saline) before and after surgery and the same dose will be given postoperatively at 8hour intervals for 24hours.

Outcomes

Primary Outcome Measures

Postoperative analgesic consumption
Comparison of total analgesic consumption between 3 groups in morphine equivalent

Secondary Outcome Measures

Postoperative analgesic consumption
Comparison of total analgesic consumption between 3 groups in morphine equivalent
Post operative pain scores
Comparison of NRS(numerical rating scale: 0, no pain, 10, worst possible pain) between 3 groups: Worst (cough) and mean pain scores
Frequency of side effects of opioids
respiratory depression, postoperative nausea/vomiting, itching, constipation
Quality of recovery questionaire
self reported Quality of recovery-15 (QoR-15: 0, very poor recovery, 150, excellent recovery) questionnaire
Postoperative recovery
Timing of oral intake(hr), timing of ambulation(hr)
Length of hospital day
postoperative hospital stay(days), intensive care unit admission(days)

Full Information

First Posted
June 28, 2021
Last Updated
December 27, 2022
Sponsor
Asan Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04959591
Brief Title
Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery
Official Title
Use of Intravenous Acetaminophen in Adolescents and Pediatrics Undergoing Spinal Fusion Surgery: Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
April 15, 2022 (Actual)
Study Completion Date
April 22, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Asan Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
The purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery.
Detailed Description
Spinal fusion surgery to correct scoliosis causes severe postoperative pain in adolescents and pediatric patients. Thus, appropriate control of postoperative pain has a significant impact on postoperative recovery, patient satisfaction and reduction of hospital stay. Although pain control was achieved through only opioids, the importance of multimodal analgesia has recently been emphasized as opioid addiction and side effects increase. Acetaminophen is recommended as a key factor in multimodal analgesia and previous studies performed in adult spine surgery showed that intravenous administration of acetaminophen reduced the postoperative pain and opioid consumption. In addition, acetaminophen is a drug widely recognized for safety in adolescents and pediatric patients and has a fast and predictable analgesic effect. Therefore, the purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery. Thus the specific aim of this trial the investigators will determine is; The decrease in postoperative analgesic requirement following IV acetaminophen The decrease in intensity of postoperative pain following IV acetaminophen The quality of recovery including self-reported recovery, physical and functional recovery and length of stay The preemptive analgesic effect of IV acetaminophen

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scoliosis; Adolescence
Keywords
scoliosis, acetaminophen

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
The designated research pharmacist will prepare the both study drug (IV acetaminophen) and placebo and will dispense the study drug according to treatment allocation. Treatment allocation will remain concealed from all other investigators involved in the conduct and analysis of the trial. All other medical staff involved in patient care during the hospital stay of study participant and the study participants itself along with guardians will be also blinded throughout.
Allocation
Randomized
Enrollment
99 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental (Pre): Acetaminophen
Arm Type
Experimental
Arm Description
Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg after anesthetic induction/before surgical incision and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given at the end of surgery before skin closure.
Arm Title
Experimental(post): Acetaminophen
Arm Type
Experimental
Arm Description
Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg at the end of surgery before skin closure and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given after anesthetic induction/before surgical incision.
Arm Title
Placebo comparator : placebo
Arm Type
Placebo Comparator
Arm Description
Participants will receive 1.5ml/kg placebo (0.9% saline) before and after surgery and the same dose will be given postoperatively at 8hour intervals for 24hours.
Intervention Type
Drug
Intervention Name(s)
intravenous acetaminophen
Intervention Description
experimental(pre): administration of IV acetaminophen
Intervention Type
Drug
Intervention Name(s)
intravenous acetaminophen
Intervention Description
experimental(post): administration of IV acetaminophen
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
placebo comparator: administration of normal saline
Primary Outcome Measure Information:
Title
Postoperative analgesic consumption
Description
Comparison of total analgesic consumption between 3 groups in morphine equivalent
Time Frame
24 hours after surgery
Secondary Outcome Measure Information:
Title
Postoperative analgesic consumption
Description
Comparison of total analgesic consumption between 3 groups in morphine equivalent
Time Frame
48 hours after surgery
Title
Post operative pain scores
Description
Comparison of NRS(numerical rating scale: 0, no pain, 10, worst possible pain) between 3 groups: Worst (cough) and mean pain scores
Time Frame
4, 8, 24, 48 hours after surgery
Title
Frequency of side effects of opioids
Description
respiratory depression, postoperative nausea/vomiting, itching, constipation
Time Frame
24, 48, 72 hours after surgery
Title
Quality of recovery questionaire
Description
self reported Quality of recovery-15 (QoR-15: 0, very poor recovery, 150, excellent recovery) questionnaire
Time Frame
3 to 5 days after surgery
Title
Postoperative recovery
Description
Timing of oral intake(hr), timing of ambulation(hr)
Time Frame
from end of surgery to discharge from hospitalization (average 7 days)
Title
Length of hospital day
Description
postoperative hospital stay(days), intensive care unit admission(days)
Time Frame
from end of surgery to discharge from hospitalization (average 7 days)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
11 Years
Maximum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists (ASA) physical status 1-3 patients undergoing spinal fusion surgery Exclusion Criteria: patients who refuse to participate in this study patients unable to communicate due to mental impairment or developmental delay patients allergic to acetaminophen or its additives or who are contraindicated in acetaminophen administration for other reasons patients with existing liver diseases or dysfunction (i.e. active hepatitis, clinically relevant chronic liver conditions, elevated liver enzymes) patients who are judged ineligible by the medical staff to participate in the study for other reasons
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Won Uk Koh, M.D, Ph.D
Organizational Affiliation
Asan Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asan Medical Center
City
Seoul
ZIP/Postal Code
05505
Country
Korea, Republic of

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26035501
Citation
Shastri N. Intravenous acetaminophen use in pediatrics. Pediatr Emerg Care. 2015 Jun;31(6):444-8; quiz 449-50. doi: 10.1097/PEC.0000000000000463.
Results Reference
background
PubMed Identifier
28564673
Citation
Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017 Jul 1;152(7):691-697. doi: 10.1001/jamasurg.2017.0898.
Results Reference
background
PubMed Identifier
23299606
Citation
Ceelie I, de Wildt SN, van Dijk M, van den Berg MM, van den Bosch GE, Duivenvoorden HJ, de Leeuw TG, Mathot R, Knibbe CA, Tibboel D. Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA. 2013 Jan 9;309(2):149-54. doi: 10.1001/jama.2012.148050.
Results Reference
background

Learn more about this trial

Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery

We'll reach out to this number within 24 hrs